GXI.DE · STOCK
Gerresheimer AG (GRRMY.US)
Gerresheimer at a Glance
Gerresheimer AG is a German packaging powerhouse for pharmaceuticals, supplying vials, syringes, and drug delivery devices to big pharma and biotech firms. It operates in an oligopoly serving the essential — but unglamorous — world of medicine packaging. Key metrics tell a story of growth amid pressure: TTM revenue hit €2.3B, but gross margins sit at 26.9% and operating margins a slim 1.3%, hammered by 18.2% capex intensity for expansions. Market cap ~$0.7B reflects undervaluation at 6x forward P/E. Competitive edge comes from scale and regulatory lock-in, but high debt (€0.9B) and customer concentration pose risks in a regulated niche.
- Market cap
- $718.4M
- Revenue (TTM)
- €2.3B
- Gross margin
- 26.9%
- Operating margin
- 1.3%
- P/E (TTM)
- 26.00
- P/S
- 0.32
- EV/EBITDA
- 6.99
- Dividend yield
- 0.8%
- Beta
- 0.33
- 52-week high
- $18.65
- 52-week low
- $4.71
- Employees
- 13,535
What Gerresheimer Does and Why It Matters
Gerresheimer AG is a specialized manufacturer in the pharmaceutical supply chain, focusing on packaging and drug delivery systems that ensure medicines reach patients safely and effectively. This section breaks down the company's identity, financial snapshot, and core positioning — essential for understanding its role in healthcare. The company operates through three divisions: Plastics & Devices (47% of revenue), Primary Packaging Glass (42%), and Advanced Technologies (11%). TTM revenue reached €2.3B, with a gross margin of 26.9% and operating margin of just 1.3%. High capital expenditures at 18.2% of revenue reflect heavy investments in capacity, while market cap hovers around $0.7B. Headquartered in Düsseldorf, Germany, it employs 13,535 people and serves pharma, biotech, diagnostics, and cosmetics via a B2B model. These numbers reveal a business in transition: stable but low-margin packaging anchors revenue, yet growth hinges on high-capex expansions into drug delivery. That tension — thin profitability versus biologics-driven upside — shapes Gerresheimer's story, linking directly to how it generates revenue from customers.…